Screening for atrial fibrillation in primary care

Heart

Volumn 79, Issue 1, 1998, Pages 50-55

  Wheeldon, N M ^a   Tayler, D I ^b   Anagnostou, E ^a   Cook, D ^a   Wales, C ^a   Oakley, G D G ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b NORTH GENERAL HOSPITAL   (United States)

Author keywords

Anticoagulant treatment; Atrial fibrillation; Primary care

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCREENING TEST; TREATMENT INDICATION;

EID: 0031969823     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.79.1.50     Document Type: Article

References (24)

1. Wheeldon NM. Atrial fibrillation and anticoagulant therapy. Eur Heart J 1995;16:302-12.
2. Ezekowitz MD, Bridges SL, James KE, et al for The Veterans Affairs Stroke Prevention in Non-rheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 1992;327:1406-12.
3. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Circulation 1991;84: 527-39.
4. Ostrander LD, Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan. Circulation 1965;31:888-98.
5. Rose G, Baxter PI, Reid DD, et al. Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J 1978;40:636-43.
6. Onundarson PT, Thorgeirsson G, Jomundsson E, et al. Chronic atrial fibrillation - epidemiologic features and 14 year follow-up: a case-control study. Eur Heart J 1987;8: 521-7.
7. Hill ID, Mottram EM, Killeen PD. Study of the prevalence of atrial fibrillation in general practice patients over 65 years of age. JR Coll Gen Pract 1987;37:172-3.
8. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-4.
9. Lake FR, Cullen KJ, de Klerk NH, et al. Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 1989;19:321-6.
10. Chang HI, Bell JR, Deroo DB, et al. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med 1990;150:81-4.
11. Kutner M. Physicians attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991;151: 1950-3.
12. Sudlow CM, Rodgers H, Kenny RA, et al. Service provision and use of anticoagulants in atrial fibrillation. BMJ 1995;311:558-61.
13. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
14. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11.
15. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-20.
16. Weyman AK. In: Principles and practice of echocardiography, 2nd ed. Boston: Lea and Febiger, 1994:647-9.
17. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
18. Moulton AW, Singer DE, Haas JS. Risk-factors for stroke in patients with non-rheumatic atrial fibrillation: a case-control study. Am J Med 1991;91:156-61.
19. Gustafsson C, Asplund K, Britton M, et al. Cost-effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective. BMJ 1992;305: 1457-60.
20. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982;306:1018-22.
21. Wheeldon NM, Macdonald TM, Flucker C, et al. Echocardiography in chronic heart failure in the community. Q J Med 1993;86:17-23.
22. Clarkson PBM, Prasad N, Wheeldon NM, et al. Echocardiographic screening of patients treated with loop diuretics in primary care [abstract]. Amsterdam: Proceedings of Heart Failure '95:101.
23. Poller L, Wright D, Rowland SM. Prospective comparative study of computer programmes used for management of warfarin. J Clin Pathol 1993;46:299-303.
24. Mackie C. Nurse practitioners managing anticoagulant clinics. Nursing Times 1996;(3):25-6.